Phase 1 Holdings

Phase I Clinical Research, formerly operating under Phase 1 Holdings, is a contract research organization (CRO) specializing in Phase I and Phase IIa clinical trials. Based in Miami, Florida, the company provides a full suite of clinical pharmacology services, including protocol development, recruitment of healthy volunteers and patient populations, and trial management. The firm is recognized for its expertise in complex, first-in-human studies and specialized therapeutic areas such as neurology and infectious diseases. In May 2019, Phase 1 Holdings was acquired by Altasciences, a leading mid-size CRO, to expand its clinical trial footprint in the United States. Today, the facility operates as a key clinical site within the Altasciences global network.